EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in extracellular Vesicle-based cancer precision medicine

Hema Saranya Ilamathi, Gina Rinaldo, Oscar P B Wiklander

Cancer Letters · 2025

DOI: 10.1016/j.canlet.2025.217976 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Letters, 2025. Verfasst von Hema Saranya Ilamathi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Unit for Biomolecular and Cellular Medicine, Karolinska Institutet, Stockholm, Sweden; Breast Center, Karolinska C…. Hauptthemen laut MEDLINE: Extracellular Vesicles, Precision Medicine, Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council, Swedish Cancer Foundation, Karolinska Institutet.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer precision medicine has spurred tremendous research interest in recent years. An emerging field in cancer therapy utilizes extracellular vesicles (EVs), which are natural nanoparticles that are now recognized as key players in intercellular communication. With targeting potential and their inherent ability to transport molecules, EVs demonstrate great promise in the field of drug delivery. Targeted oncotherapy aims to hit the cancer's bull's eye while avoiding off-target effects associated with traditional treatment strategies. However, the dynamic nature of cancer cells limits the effectiveness of treatment based solely on cancer antigens. The tumour microenvironment is an important factor in cancer development and progression, providing yet another means to target. In this review, we discuss potential tumour microenvironment-associated antigens that have been tested in preclinical and clinical trials. We also discuss how EVs could be engineered to target these antigens in a multi-armed cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesPrecision MedicineNeoplasmsHumansTumor MicroenvironmentAnimalsDrug Delivery SystemsAntigens, Neoplasm

Stichwörter der Autor:innen

AntibodiesCancerExtracellular vesiclesTargeted therapyTumour microenvironment

Substanzen

Antigens, Neoplasm

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Unit for Biomolecular and Cellular Medicine, Karolinska Institutet, Stockholm, Sweden; Breast Center, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Stockholm,…

Förderung

  • Swedish Research Council
  • Swedish Cancer Foundation
  • Karolinska Institutet
  • Center for Innovative Medicine
  • Cancerfonden
  • Cancer Research Foundations of Radiumhemmet

Zitieren

APA

Ilamathi, H. S., Rinaldo, G., & Wiklander, O. P. B. (2025). Advances in extracellular Vesicle-based cancer precision medicine. Cancer Letters. https://doi.org/10.1016/j.canlet.2025.217976

Vancouver

Ilamathi HS, Rinaldo G, Wiklander OPB. Advances in extracellular Vesicle-based cancer precision medicine. Cancer Letters. 2025. doi:10.1016/j.canlet.2025.217976

BibTeX
@article{Ilamathi2025,
  author = {Ilamathi, Hema Saranya and Rinaldo, Gina and Wiklander, Oscar P B},
  title = {Advances in extracellular Vesicle-based cancer precision medicine},
  journal = {Cancer Letters},
  year = {2025},
  doi = {10.1016/j.canlet.2025.217976}
}
Kostenlos starten →